Regeneron Pharmaceuticals | Marktkapitalisierung

Aktienkurs
778.95
Täglich Wechseln
-8.09 -1.03%
Monatlich
2.14%
Jährlich
7.67%
Q1 Prognose
755.50




Marktkapitalisierung Veränderung Datum
AbbVie USD 391.49B 12.34B 2026-02
Agenus USD 204M 164M 2025-06
Agios Pharmaceuticals USD 1.6B 16M 2026-02
Alnylam Pharmaceuticals USD 39.74B 12.8B 2026-02
Amgen USD 201.45B 25.2B 2026-02
Astellas Pharma JPY 4.33T 546.23B 2026-02
AstraZeneca USD 222.33B 65.82B 2026-02
Biogen USD 27.01B 1.19B 2026-02
BioMarin Pharmaceutical USD 11.99B 575M 2026-02
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Eli Lilly USD 1.01T 3.37B 2026-02
Esperion Therapeutics USD 340M 235M 2023-12
Gilead Sciences USD 183.59B 31.31B 2026-02
GlaxoSmithKline GBP 87.33B 12.98B 2026-02
Incyte USD 22.7B 3.31B 2026-02
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
J&J USD 500.24B 67.44B 2025-12
Kyowa Hakko Kirin JPY 1.36T 28.23B 2026-02
Merck USD 300.37B 39.11B 2026-02
Moderna USD 16.5B 6.41B 2026-02
Neurocrine Biosciences USD 13.68B 465M 2026-02
Novartis USD 265.66B 9.48B 2025-09
Novartis USD 303.91B 57.84B 2026-02
Pfizer USD 152.89B 11.32B 2026-02
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 118.94B 1.6B 2026-02
Sarepta Therapeutics USD 2.02B 336M 2025-09
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Ultragenyx Pharmaceutical USD 1.94B 284M 2026-02
United Therapeutics USD 18.96B 6B 2025-09
Vertex Pharmaceuticals USD 120.12B 5.09B 2026-02


Regeneron Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.